Modalities
Platforms
DNA & Plasmid Platforms
High-quality plasmid DNA platforms
powering RNA，gene and cell therapies.
RNA Therapeutics Platforms
Integrated RNA platforms spanning mRNA,
circular RNA, and self-amplifying RNA.
LNP / tLNP Delivery Systems
Advanced lipid-based delivery systems
enabling precise in vivo targeting.
Polymer & Other Novel Delivery Systems
Next-generation non-lipid delivery systems
for emerging therapeutic needs
Protein & Peptide Manufacturing Platforms
Scalable microbial manufacturing for
proteins, nanobodies, and peptides.
GMP Manufacturing & CMC Platforms
End-to-end GMP manufacturing and CMC
support from IND to scale-up.
Services
CRDMO Service Overview
Analytical & QC
Quality & GMP
Ecosystem & Partnerships
Ecosystem & Partnerships
News
Resources
About Us
Company Profile
Corporate Culture
Facilities
Company History
Careers
contact
Catalog Order
CN
菜单
搜索
Modalities
Cancer & Therapeutic Immunotherapies
In Vivo Cell Therapies
Ex Vivo Cell Therapy
Protein Replacement Therapies
Gene Editing (RNA-enabled)
Prophylactic Infectious Disease Vaccines
Protein & Peptide Therapeutics
Platforms
DNA & PlasmidPlatforms
RNA Therapeutics Platform
LNP / tLNP Delivery Systems
Polymer & Other Novel Delivery Systems
Protein & Peptide Manufacturing Platforms
GMP Manufacturing & CMC Platforms
Services
Services Overview
Analytical Development & QC
Quality Grades & GMP Readiness
Ecosystem & Partnerships
News
Resources
Learning Center
About Us
Company Profile
Corporate Culture
Facilities
Company History
Careers
contact
Contact Us
Catalog Order
News
May 10 , 2026
CATUG @ ASGCT 2026 | Global Expansion in Boston
May 6 , 2026
CATUG at ASGH 2026: Accelerating Nucleic Acid Innovation in Hong Kong
April 23 , 2026
CATUG to Showcase at mRNA Conference 2026
April 1 , 2026
CATUG Launches RNA-LNP Lyophilization Production Line, Accelerating Next-Generation RNA Therapeutics Delivery
January 1 , 2026
International Expansion | CATUG: From JPM Roundtable to Berlin mRNA Summit, Insights into the Future of Multi-Modal RNA
August 13 , 2025
CATUG Congratulates QIHAN BIOTECH on FDA Approval for QT-019B Clinical Trial
«
1
2
»
contact us